Investors



EXCHANGE: NASDAQ
Change
Change (%)
Volume
Data as of
Minimum 15 minute delay
Refresh quote

LEARN MORE

INVESTOR KIT

Recent Press Releases

  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today its participation during Digestive Disease Week 2019 (“DDW”). DDW will be held May 18-21, 2019 at the San Diego Convention Center in San Diego, California. Apollo’s OverStitch™ Endoscopic Suturing System and ORBERA® Intragastric Balloon, will bemore...
  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Endo-bariatric sales, representing our core business moving forward, increased 5% from $10.3 million to $10.8 million, with ESS salesmore...
Business Wire InvestorHQ℠